Bacterial particles retard tumor growth as a novel vascular disrupting agent

被引:7
|
作者
Guo, Fengzhu [1 ,2 ,3 ,4 ]
Ji, Gaili [1 ,2 ,3 ]
Li, Qiqi [1 ,2 ,3 ]
Yang, Yun [1 ,2 ,3 ]
Shui, Lin [1 ,2 ,3 ]
Shen, Yuge [1 ,2 ,3 ]
Yang, Hanshuo [1 ,2 ,3 ]
机构
[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Sichuan, Peoples R China
[3] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[4] Sichuan Univ, Lung Canc Ctr, West China Hosp, Chengdu 610041, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Bacterial particle; Vascular disrupting agent; Tumor microenvironments; Inflammatory cytokines; TARGETED THERAPY; CANCER; CELLS; ANGIOGENESIS; VEGF; RECRUITMENT; MECHANISMS; RESISTANCE; HYPOXIA;
D O I
10.1016/j.biopha.2019.109757
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Due to hypoxia and poor circulation in the tumor interior, malignant cells in solid tumors are resistant to traditional therapies. In the present study, we reported that bacterial particles (BactPs) functioned effectively in retarding tumor growth as a novel vascular disrupting agent. The BactPs were inactivated intact bacteria. Intravenous administration of BactPs extensively disrupted vessels in the tumor interior, but not in normal organs, and resulted in tumor hemorrhage and necrosis in six hours. We revealed that the extensive disruption of tumor vasculature was due to drastic changes in the inflammatory factors in mice sera and the tumor micro-environments, indicating the critical role of the host immune response to the BactPs. Furthermore, we showed that a combination of six inflammatory cytokines was capable of inducing tumor hemorrhage and necrosis, similar to the effects of the BactPs. Together, these results suggest that BactPs are a novel kind of tumor vascular disruptor with a promising potential for solid tumor treatment.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Characterizing the tumor response to vascular disrupting agent treatment
    Salmon, Beth A.
    Siemann, Dietmar W.
    CANCER RESEARCH, 2006, 66 (08)
  • [2] Effects of ASA404, a vascular disrupting agent, on tumor growth of gastric cancer in an experimental model
    Lang, S. A.
    Moser, C.
    Jung, E. M.
    Pfister, K.
    Geissler, E. K.
    Schlitt, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [3] Effects of the vascular disrupting agent ASA404 on tumor growth of gastric cancer in an experimental model
    Moser, Christian
    Lang, Sven A.
    Jung, Ernst M.
    Pfister, Karin
    Geissler, Edward K.
    Schlitt, Hans J.
    CANCER RESEARCH, 2011, 71
  • [4] Combretastatin A4 phosphate: a novel vascular disrupting agent
    Nagaiah, Govardhanan
    Remick, Scot C.
    FUTURE ONCOLOGY, 2010, 6 (08) : 1219 - 1228
  • [5] NPI-2358, a Novel Vascular Disrupting Agent Blocks Growth and Angiogenesis in Multiple Myeloma Cells
    Chauhan, Dharminder
    Singh, Ajita V.
    Bandi, Madhavi
    Raje, Noopur
    Schlossman, Robert L.
    Lloyd, G. Kenneth
    Richardson, Paul
    Palladino, Michael A.
    Anderson, Kenneth C.
    BLOOD, 2009, 114 (22) : 1478 - 1478
  • [6] Development of a Novel Tumor-Targeted Vascular Disrupting Agent Activated by Membrane-Type Matrix Metalloproteinases
    Atkinson, Jennifer M.
    Falconer, Robert A.
    Edwards, Dylan R.
    Pennington, Caroline J.
    Siller, Catherine S.
    Shnyder, Steven D.
    Bibby, Michael C.
    Patterson, Laurence H.
    Loadman, Paul M.
    Gill, Jason H.
    CANCER RESEARCH, 2010, 70 (17) : 6902 - 6912
  • [7] Vascular disrupting agent induced aggregation of gold nanoparticles for photothermally enhanced tumor vascular disruption
    Hong, Sheng
    Zheng, Di-Wei
    Zhang, Cheng
    Huang, Qian-Xiao
    Cheng, Si-Xue
    Zhang, Xian-Zheng
    SCIENCE ADVANCES, 2020, 6 (23)
  • [8] Preclinical studies of the novel vascular disrupting agent MN-029
    Shi, WY
    Siemann, DW
    ANTICANCER RESEARCH, 2005, 25 (6B) : 3899 - 3904
  • [9] Preclinical profile of NPI-2358, a tumor vascular disrupting agent.
    Lloyd, GK
    Wilson, L
    Bishop, J
    Nicholson, B
    Paladino, M
    Borgström, P
    Honess, DJ
    Tozer, GM
    Siemann, DW
    Mangold, G
    Kiso, Y
    Neuteboom, ST
    Hayashi, Y
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9033S - 9033S
  • [10] Impact of circulating endothelial progenitor cells on the growth of viable tumor rim after treatment with a vascular disrupting agent.
    Shaked, Yuval
    Ciarrocchi, Alessia
    Franco, Marcela
    Lee, Christina R.
    Man, Shan
    Cheung, Alison
    Hicklin, Daniel
    Foster, Stuart
    Benezra, Robert
    Kerbel, Robert S.
    CANCER RESEARCH, 2006, 66 (08)